Clinical Impact of PD-L1 Expression for Survival in Curatively Resected Colon Cancer.

Cancer Invest

Department of Surgery, Gil Medical Center, College of Medicine, Gachon University, Incheon, Korea.

Published: August 2020

Background: Programmed death 1 (PD-1) and its ligand PD-L1 play a key dysfunction of T lymphocytes. The purpose of this study was to assess and compare the prognostic role of tumor- TILs and its relationship with PD-L1 expression in stage II and III colon cancer.

Methods: Immunohistochemisty was used to assess the densities of CD8, CD4, and FOXP3 cells, and PD-L1 expression in intraepithelial tumor site from 58 stage II and III colon cancers. These were evaluated for association with histopathologic features and overall survival.

Results: PD-L1-positive tumors contained a higher number of CD8 TILs with statistical significance ( = 0.001). CD4 TILs showed positive correlation with PD-L1 expression ( = 0.034). There were no associations between PD-L1 expression and FOXP3 TILs. Microsatellite instability (MSI)-high status ( = 0.001; Odd ration 18.0; 95% CI = 4.3-74.8) was the strongest prognostic factor along with mucinous/poor cell differentiation, CD8 and right tumor location was associated with PD-L1 expression ( = 0.024, 0.035 and 0.033, respectively).

Conclusion: This study demonstrated that PD-L1 expression was associated with MSI-high, increased CD8 TILs, mucinous and poor cell differentiation, and right-sided tumor location.

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357907.2020.1793349DOI Listing

Publication Analysis

Top Keywords

pd-l1 expression
28
pd-l1
8
stage iii
8
iii colon
8
cd8 tils
8
cell differentiation
8
tumor location
8
expression
7
tils
5
clinical impact
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!